#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Skin cancer Ureteric cancer Medulloblastoma recurrent Loeys-Dietz syndrome Oesophageal adenocarcinoma stage III Pancreatic carcinoma metastatic Nephropathy Encephalitis autoimmune Hyperinsulinism Neurodermatitis Nasopharyngeal cancer Epstein-Barr virus associated lymphoproliferative disorder Behcet's syndrome Thrombocytosis Oropharyngeal cancer recurrent More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Diagnostics Hereditary hypophosphataemic rickets – Life with Disease Leiomyosarcoma – Diagnostics Myelodysplastic syndrome with excess blasts – Life with Disease Richter’s syndrome Cerebral arteriovenous malformation haemorrhagic – Life with Disease Alexander disease – Diagnostics Osteosarcoma recurrent – Life with Disease Ewing’s sarcoma – Diagnostics Mantle cell lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zinc Sulphate Heptahydrate Nitrofurantoin Upacicalcet Sodium Hydrate Diclofenac Sodium Arachis Hypogaea Extract Cefoxitin Sodium X-396 Clavulanic Acid Gadobenate Dimeglumine Nomegestrol Acetate Contezolid Mirtazapine Lt3001 Betaxolol REGN7544 RNMB3 Raxtozinameran Bexotegrast Amikacin Sulfate BI-1607 More therapies…

    Learn about Your Condition

    Ovarian cancer Lung adenocarcinoma stage III Pharyngeal cancer stage II Anogenital dysplasia Pyoderma Skin angiosarcoma Myocardial infarction Rubella Gestational diabetes Mucopolysaccharidosis III Mantle cell lymphoma stage III Anaplastic thyroid cancer Hysterectomy Deep vein thrombosis Asthma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immunoglobulin G4 related disease

  • A study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease

    Recruiting

    3 1
    Belgium France Germany Italy The Netherlands Poland +2

  • A study to evaluate the safety and effects of inebilizumab in children and adolescents with immunoglobulin G4-related disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Inebilizumab
    Greece Italy Poland Spain

  • Study of 18F-AlF-FAPI-74 PET/CT imaging compared to standard 18F-FDG PET/CT in patients with fever of unknown origin, IgG4-related disease, and axial spondyloarthritis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Immunoglobulin G4 related disease
    • Pyrexia
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Belgium

  • Study on Abatacept for Patients with IgG4-Related Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Immunoglobulin G4 related disease
    Investigated Drugs:
    • Abatacept
    Italy

  • Study on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Antisynthetase syndrome
    • Immunoglobulin G4 related disease
    • Behcet’s syndrome
    Investigated Drugs:
    • Filgotinib
    The Netherlands

  • Study on the Effectiveness of Inebilizumab for Patients with IgG4-Related Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immunoglobulin G4 related disease
    Investigated Drugs:
    • Inebilizumab
    France Germany Italy The Netherlands Poland Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!